Gmo Emerging is trading at 26.41 as of the 21st of June 2025; that is 1.38 percent decrease since the beginning of the trading day. The fund's open price was 26.78. Gmo Emerging has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 26th of June 2024 and ending today, the 21st of June 2025. Click here to learn more.
Under normal circumstances, the fund invests at least 80 percent of the funds net assets directly and indirectly in companies tied economically to markets that are not treated as developed markets in the MSCI World Index . GMO Emerging is traded on NASDAQ Exchange in the United States.. More on Gmo Emerging Markets
Gmo Emerging Markets [GMOEX] is traded in USA and was established 21st of June 2025. Gmo Emerging is listed under GMO category by Fama And French industry classification. The fund is listed under Diversified Emerging Mkts category and is part of GMO family. This fund currently has accumulated 3.78 B in assets under management (AUM) with no minimum investment requirementsGmo Emerging Markets is currently producing year-to-date (YTD) return of 9.62% with the current yeild of 0.05%, while the total return for the last 3 years was 6.21%.
Check Gmo Emerging Probability Of Bankruptcy
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance